Primary |
Attention Deficit/hyperactivity Disorder |
50.4% |
Ill-defined Disorder |
12.3% |
Product Used For Unknown Indication |
10.5% |
Drug Use For Unknown Indication |
7.8% |
Depression |
3.0% |
Apathy |
1.7% |
Foetal Exposure During Pregnancy |
1.7% |
Disturbance In Attention |
1.6% |
Oppositional Defiant Disorder |
1.6% |
Major Depression |
1.3% |
Insomnia |
1.0% |
Obsessive-compulsive Disorder |
1.0% |
Psychomotor Hyperactivity |
1.0% |
Sleep Disorder |
0.9% |
Suicide Attempt |
0.9% |
Dementia Alzheimer's Type |
0.7% |
Diabetes Mellitus |
0.7% |
Psychomotor Retardation |
0.7% |
Abnormal Behaviour |
0.6% |
Autism |
0.6% |
|
Tic |
17.2% |
Intentional Overdose |
16.2% |
Vomiting |
6.9% |
Overdose |
6.4% |
Therapeutic Response Unexpected With Drug Substitution |
5.9% |
Sudden Death |
5.4% |
Suicidal Ideation |
4.9% |
Suicide Attempt |
4.4% |
Drug Ineffective |
3.9% |
Completed Suicide |
2.9% |
Death |
2.9% |
Flushing |
2.9% |
Restlessness |
2.9% |
Road Traffic Accident |
2.9% |
Drug Abuse |
2.5% |
Irritability |
2.5% |
Maternal Drugs Affecting Foetus |
2.5% |
Product Substitution Issue |
2.5% |
Weight Increased |
2.5% |
Arrhythmia |
2.0% |
|
Secondary |
Attention Deficit/hyperactivity Disorder |
37.0% |
Drug Use For Unknown Indication |
19.2% |
Product Used For Unknown Indication |
17.2% |
Obsessive-compulsive Disorder |
3.1% |
Depression |
2.7% |
Narcolepsy |
2.5% |
Bipolar I Disorder |
2.2% |
Apathy |
1.8% |
Traumatic Brain Injury |
1.4% |
Bipolar Disorder |
1.3% |
Cataplexy |
1.3% |
Major Depression |
1.3% |
Psychomotor Hyperactivity |
1.3% |
Self Injurious Behaviour |
1.3% |
Ill-defined Disorder |
1.2% |
Intentional Overdose |
1.2% |
Hypothyroidism |
1.1% |
Oppositional Defiant Disorder |
1.1% |
Abnormal Behaviour |
0.9% |
Hypertension |
0.9% |
|
Tic |
15.3% |
Suicide Attempt |
9.3% |
Completed Suicide |
6.7% |
Acute Myeloid Leukaemia |
5.3% |
Respiratory Arrest |
5.3% |
Suicidal Ideation |
5.3% |
Vomiting |
5.3% |
Fatigue |
4.7% |
Serotonin Syndrome |
4.7% |
Drug Ineffective |
4.0% |
Flushing |
4.0% |
Obsessive-compulsive Disorder |
4.0% |
Restlessness |
4.0% |
Hypertension |
3.3% |
Psychotic Disorder |
3.3% |
Tachycardia |
3.3% |
Therapeutic Response Decreased |
3.3% |
Vertigo |
3.3% |
Colonic Polyp |
2.7% |
Eye Swelling |
2.7% |
|
Concomitant |
Drug Use For Unknown Indication |
29.2% |
Attention Deficit/hyperactivity Disorder |
12.9% |
Pain |
7.5% |
Depression |
6.9% |
Narcolepsy |
4.9% |
Product Used For Unknown Indication |
3.9% |
Multiple Sclerosis |
3.6% |
Hypertension |
3.3% |
Constipation |
3.3% |
Asthma |
3.0% |
Hiv Infection |
3.0% |
Bipolar Disorder |
2.8% |
Cataplexy |
2.8% |
Rheumatoid Arthritis |
2.2% |
Insomnia |
2.1% |
Anxiety |
2.0% |
Ill-defined Disorder |
1.9% |
Non-small Cell Lung Cancer |
1.8% |
Crohn's Disease |
1.6% |
Nausea |
1.5% |
|
Weight Decreased |
14.4% |
Vomiting |
10.3% |
Diabetic Ketoacidosis |
6.2% |
Tachycardia |
6.2% |
Weight Increased |
6.2% |
Pulmonary Embolism |
5.2% |
Tic |
4.6% |
Tremor |
4.6% |
Pyrexia |
4.1% |
Renal Failure |
4.1% |
Somnolence |
4.1% |
Suicidal Ideation |
4.1% |
Drug Ineffective |
3.6% |
Rectal Haemorrhage |
3.6% |
Type 2 Diabetes Mellitus |
3.6% |
Aggression |
3.1% |
Myocardial Infarction |
3.1% |
Treatment Noncompliance |
3.1% |
Urticaria |
3.1% |
Anaphylactic Reaction |
2.6% |
|
Interacting |
Attention Deficit/hyperactivity Disorder |
28.6% |
Drug Use For Unknown Indication |
27.1% |
Bipolar Disorder |
8.6% |
Mental Impairment |
5.7% |
Epilepsy |
4.3% |
Induction Of Anaesthesia |
4.3% |
Aggression |
2.9% |
Anaesthesia |
2.9% |
Depressed Mood |
2.9% |
Depression |
2.9% |
Negativism |
2.9% |
Contraception |
1.4% |
Insomnia |
1.4% |
Mania |
1.4% |
Oppositional Defiant Disorder |
1.4% |
Smoking Cessation Therapy |
1.4% |
|
Drug Interaction |
45.0% |
Oculogyric Crisis |
15.0% |
Mania |
10.0% |
White Blood Cell Count Increased |
10.0% |
Feeling Abnormal |
5.0% |
Irritability |
5.0% |
Performance Status Decreased |
5.0% |
Serotonin Syndrome |
5.0% |
|